SG/CALL/BAYER/65/0.1/20.12.24 | Market Closed - Deutsche Boerse AG 20:47:58 17/05/2024 BST | ||
| 0.005 EUR | +400.00% |
|
| 1 month | -44.44% | ||
| 3 months | -64.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 0.005 | +400.00% |
| 16/05/24 | 0.001 | -50.00% |
| 15/05/24 | 0.002 | -33.33% |
| 14/05/24 | 0.003 | -50.00% |
| 13/05/24 | 0.006 | +20.00% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 08:47 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| WKN | SQ6N7R |
| ISIN | DE000SQ6N7R0 |
| Date issued | 21/12/2022 |
| Strike | 65 € |
| Maturity | 20/12/2024 (215 Days) |
| Parity | 10 : 1 |
| Emission price | 0.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.91 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.58
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.13%
- Stock Market
- Warrants
- Warrant
